Skip to main content

World AIDS Day

December 1st marks World AIDS Day, a globally recognized occasion dedicated to raising awareness of the AIDS pandemic and mourning those we have lost. The fight against HIV/AIDS has seen monumental strides, largely due to the ceaseless efforts of the scientific community. In light of this annual observance, we are thrilled to present a special collection of articles that will exclusively examine the scientific studies relating to HIV/AIDS, both retrospectively and prospectively.

Retrospective Analyses: The Science of Progress
The retrospective section will feature articles analyzing the scientific discoveries that have shaped our current understanding of HIV/AIDS. It will revisit groundbreaking research, pivotal trials, innovative therapies, and milestones that have been critical in managing and treating this complex disease.

Prospective Investigations: Towards a Brighter Future
On the other hand, the prospective segment will offer forward-looking insights, spotlighting emerging scientific trends, cutting-edge research, and future directions. This section will foster a dialogue about the next phase in HIV/AIDS research and highlight areas where innovation, collaboration, and focused efforts are needed.

Call for Submissions: A Focus on Scientific Exploration
We welcome submissions from researchers, scientists, clinicians, and academics who are engaged in the scientific study of HIV/AIDS. Submissions may include, but are not limited to:

    â€¢ Effects and long-term consequences of co-infections with HIV 
    â€¢ Advances in treatment and prevention
    â€¢ Immunological and genetic research
    â€¢ Epidemiological studies and global health
    â€¢ Interdisciplinary research exploring new frontiers in HIV/AIDS

This collection aims to serve as a platform for showcasing rigorous scientific investigation and offers an opportunity for authors to contribute to a broader understanding of where we've come from and where we're heading in the battle against HIV/AIDS.


Please consult the submission guidelines and deadlines on the individual journal websites to be part of this unique and impactful commemoration.

Participating Journals

AIDS Research and Therapy (Editors-in-Chief: Barbara Castelnuovo, MD, PhD, Makerere University, Uganda;
Patricia Price, PhD, Curtin University, Australia)

Infectious Agents and Cancer (Editors-in-Chief: Franco M Buonaguro, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Italy; Sam M. Mbulaiteye, MBChB, MPhil, MMed, National Cancer Institute, USA; Maria Lina Tornesello, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Italy)

Journal of Health, Population and Nutrition (Editors-in-Chief: Prof Swapan K. Roy, PhD, Bangaldesh Breastfeeding Foundation, Bangladesh; Prof Orsolya Varga, PhD, University of Debrecen, Hungary)

Reproductive Health (Editor-in-Chief: Dr Sanni Yaya, PhD, University of Ottawa, Canada)

Retrovirology (Editors-in-Chief: Johnson Mak, PhD, Institute for Glycomics, Griffith University, Australia; Susan Ross, PhD, University of Illinois at Chicago, USA)

Virology Journal (Editors-in-Chief: Alan McLachlan, PhD, University of Illinois at Chicago, USA; Leo Poon, PhD, University of Hong Kong, Hong Kong)


Page 2 of 2

  1. Long-acting reversible contraception (LARC) is the most effective and reliable contraception option for female sex workers (FSWs) who desire future fertility. Unlike the other reversible contraceptive methods,...

    Authors: Simple Ouma, Nazarius Mbona Tumwesigye, Catherine Abbo and Rawlance Ndejjo
    Citation: Reproductive Health 2022 19:34
  2. The recent discovery of the role of m6A methylation in the regulation of HIV-1 replication unveiled a novel layer of regulation for HIV gene expression. This epitranscriptomic modification of HIV-1 RNAs is under ...

    Authors: Sarah N’Da Konan, Emmanuel Ségéral, Fabienne Bejjani, Maryam Bendoumou, Mélissa Ait Said, Sarah Gallois-Montbrun and Stéphane Emiliani
    Citation: Retrovirology 2022 19:4

    The Correction to this article has been published in Retrovirology 2024 21:9

  3. The NF-κB family of transcription factors and associated signalling pathways are abundant and ubiquitous in human immune responses. Activation of NF-κB transcription factors by viral pathogen-associated molecu...

    Authors: Douglas L. Fink, James Cai, Matthew V. X. Whelan, Christopher Monit, Carlos Maluquer de Motes, Greg J. Towers and Rebecca P. Sumner
    Citation: Retrovirology 2022 19:2
  4. Data on the association of human immunodeficiency virus (HIV) infection with adverse outcomes in patients with COVID-19 are conflicting. This systematic review and meta-analysis aimed to summarize the availabl...

    Authors: Celestin Danwang, Jean Jacques Noubiap, Annie Robert and Jean Cyr Yombi
    Citation: AIDS Research and Therapy 2022 19:3
  5. We developed a personalized Monocyte-Derived Dendritic-cell Therapy (MDDCT) for HIV-infected individuals on suppressive antiretroviral treatment and evaluated HIV-specific T-cell responses.

    Authors: Marcella Vassão de Almeida Baptista, Laís Teodoro da Silva, Sadia Samer, Telma Miyuki Oshiro, Iart Luca Shytaj, Leila B. Giron, Nathalia Mantovani Pena, Nicolly Cruz, Gisele Cristina Gosuen, Paulo Roberto Abrão Ferreira, Edécio Cunha-Neto, Juliana Galinskas, Danilo Dias, Maria Cecilia Araripe Sucupira, Cesar de Almeida-Neto, Reinaldo Salomão…
    Citation: AIDS Research and Therapy 2022 19:2
  6. Retention in clinical care is important for people living with HIV (PLWH). Evidence suggests that missed clinic visits are associated with interruptions in antiretroviral therapy (ART), lower CD4 counts, virol...

    Authors: Nicole Dear, Allahna Esber, Michael Iroezindu, Emmanuel Bahemana, Hannah Kibuuka, Jonah Maswai, John Owuoth, Christina S. Polyak, Julie A. Ake and Trevor A. Crowell
    Citation: AIDS Research and Therapy 2022 19:1